
    
      The study will investigate the effects of medication review and Motivational Interviewing
      (MI) on patients with Coronary Heart Disease (CHD). Clinical pharmacists competent in MI and
      cardiology will conduct medication interviews and medication reviews at the outpatient
      clinic. The intervention will continue during 9 months, with interviews and reviews as
      needed.

      Follow-up of results will take place 16 months after inclusion (corresponding to 4 months
      after the end of intervention).

      The MI-Component will be quality assured by MITI 4.2-coding (Motivational Interviewing
      Treatment Integrity). The study will investigate effects on clinical outcomes, medication
      adherence, patientsÂ´ beliefs about medicines and quality of life.
    
  